Cerebral aneurysm treatment: modern neurovascular techniques.

Endovascular treatment of cerebral aneurysm continues to evolve with the development of new technologies. This review provides an overview of the recent major innovations in the neurointerventional space in recent years

Computational fluid dynamics modeling of symptomatic intracranial atherosclerosis may predict risk of stroke recurrence.

BackgroundPatients with symptomatic intracranial atherosclerosis (ICAS) of ≥ 70% luminal stenosis are at high risk of stroke recurrence. We aimed to evaluate the relationships between hemodynamics of ICAS revealed by computational fluid dynamics (CFD) models and risk of stroke recurrence in this patient subset.MethodsPatients with a symptomatic ICAS lesion of 70-99% luminal stenosis were screened and enrolled in this study. CFD models were reconstructed based on baseline computed tomographic angiography (CTA) source images, to reveal hemodynamics of the qualifying symptomatic ICAS lesions. Change of pressures across a lesion was represented by the ratio of post- and pre-stenotic pressures. Change of shear strain rates (SSR) across a lesion was represented by the ratio of SSRs at the stenotic throat and proximal normal vessel segment, similar for the change of flow velocities. Patients were followed up for 1 year.ResultsOverall, 32 patients (median age 65; 59.4% males) were recruited. The median pressure, SSR and velocity ratios for the ICAS lesions were 0.40 (-2.46-0.79), 4.5 (2.2-20.6), and 7.4 (5.2-12.5), respectively. SSR ratio (hazard ratio [HR] 1.027; 95% confidence interval [CI], 1.004-1.051; P = 0.023) and velocity ratio (HR 1.029; 95% CI, 1.002-1.056; P = 0.035) were significantly related to recurrent territorial ischemic stroke within 1 year by univariate Cox regression, respectively with the c-statistics of 0.776 (95% CI, 0.594-0.903; P = 0.014) and 0.776 (95% CI, 0.594-0.903; P = 0.002) in receiver operating characteristic analysis.ConclusionsHemodynamics of ICAS on CFD models reconstructed from routinely obtained CTA images may predict subsequent stroke recurrence in patients with a symptomatic ICAS lesion of 70-99% luminal stenosis

Stent-assisted reconstructive endovascular repair of intracranial aneurysms: long-term clinical and angiographic follow-up

Abstract Background and Purpose: The development of self-expanding stents dedicated to intracranial use has significantly widened the applicability of endovascular therapy to many intracranial aneurysms. The purpose of this study was to report the angiographic and clinical outcomes of wide-necked intracranial aneurysms treated with stent. Methods: Between January 2007 and October 2011 we deployed 22 stents in 20 patients with wide-necked cerebral aneurysms. Inclusion criteria restricted the group to adult patients with wide-necked intracranial aneurysms (ruptured and unruptured lesions). Immediate post-procedural angiographic studies were performed to evaluate successful occlusion of the aneurysm as well as patency of the parent vessel. We assessed long term angiography follow-up to detect in-stent stenosis, progressive thrombosis, recurrence and need for retreatment. Clinical outcome was assessed with the modifing Ranking Scale (mRS). Results: Technical success was obtained in all 22 (100%) cases. Angiography immediately after treatment procedure showed complete occlusion in 7 aneurysms (35%), neck remnant in 11 (55%), incomplete occlusion in 1 (5%) and partial occlusion in 1 (5%). During the endovascular embolization procedure no rupture of the sac or bleeding complication occurred; none of the patients needed undergoing surgical crossover. Procedure-related adverse events occurred in one (5%) patient: a brachial artery pseudoaneurysm. Three (15%) patients had neurological complications after procedure, whose 1 (5%) transitory complication spontaneusly resolved. Two patients (10%), had acute complete in-stent thrombosis which resolved after intraarterial administration of abciximab and placement of a new stent in-stent. Of the 20 patients treated with stent deployment, a follow-up imaging study was available in all 19 surviving patients (95%) at an average of 16.2 months (range, 6 to 50 months). The first follow-up DSA, compared with initial angiography, showed no changes in 14 aneurysms (73.7%), progressive thrombosis in 3 (15.7%), and major recurrence in 2 (10.5%). The overall rate of succesful procedure to 6 months is 89.5%; there was 1 case of asintomatic moderate endothelial hyperplasia. The further follow-up imaging study, showed no changes in 17 (89.5%) of the 19 surviving patients, 1 progressive thrombosis and 1 minor recurrence. One month- and long term (average of 16.2 months; range, 6 to 50 months) clinical follow-up showed no worsening in the mRS in 18 (90%) of 20 patients, 1 (5%) mRS 2 and 1 (5%) mRS 6. All the survived patients are alive and we did not observe periprocedural or long-term intracranial bleeding events or symptomatic stent related stenosis/occlusion complication. Conclusions: Our findings suggest that the endovascular treatment of intracranial aneurysms by stenting is feasible, effective and safe; follow-up results proved intact parent arteries and stable occlusion rates in the majority of treated aneurysms. Nevertheless, long-term data on safety and efficacy and larger patient groups are necessary

Histologic and sonographic features of holmium laser in the treatment of chronic venous disease

A new holmium laser (HOL) has been introduced to the market. The device is able to reduce the great saphenous vein (GSV) caliber in a tumescence-free procedure, favoring an effective sclerotherapy of large vessels. Aim of the present investigation is to provide the first in vivo data about the effect of HOL on GSV histology

Acute complications of percutaneous transluminal coronary angioplasty for total occlusion

The incidence of major complications after percutaneous coronary angioplasty (PTCA) of a totally occluded artery was assessed retrospectively. A total of 1649 PTCA procedures were analyzed. After exclusion of procedures for acute myocardial infarction or total occlusion that resulted from restenosis, 90 patients wer

Vizualizacija dišnog puta: oči vide ono što mozak zna

Airway management is basic for anesthesia practice, and sometimes it can represent a really dramatic scenario for both the patient and the physicians. Laryngoscopy has been the gold standard of airway visualization for more than 60 years, showing its limitations and failure rates with time. New technology has made available an opportunity to move the physician’s eye inside patient airways thanks to video laryngoscopy and video assisted airway management technique. Undoubtedly, we have entered a new era of high resolution airway visualization and different approach in airway instrumentation. Nevertheless, each new technology needs time to be tested and considered reliable, and pitfalls and limitations may come out with careful and long lasting analysis, so it is probably not the right time yet to promote video assisted approach as a new gold standard for airway visualization, despite the fact that it certainly offers some new prospects. In any case, whatever the visualization approach, no patient dies because of missed airway visualization or failed intubation, but due to failed ventilation, which remains without doubt the gold standard of any patient safety goal and airway management technique.Održavanje dišnog puta je osnovna anesteziološka vještina koja ponekad predstavlja u pravom smislu dramatičan scenarij za bolesnika i liječnika. Laringoskopija, sa svim svojim ograničenjima i neuspjesima, predstavlja zlatni standard vizualizacije dišnog puta već više od 60 godina. Nove tehnologije, zahvaljujući videolaringoskopiji i video asistiranim tehnikamaodržavanja dišnog puta, omogućile su pomicanje očiju liječnika unutar dišnog puta bolesnika. Bez sumnje, ušli smo u novu eru visoke rezolucije vizualizacije dišnog puta i različitog pristupa instrumentalizaciji dišnog puta. Međutim, svaka nova tehnologija zahtijeva vrijeme da bi se testirala i smatrala pouzdanom. Zapreke i ograničenja mogu se iznjedriti nakon pažljive i dugotrajne analize, stoga vjerojatno još nije vrijeme da se promovira video asistirani pristup kao novi zlatni standard u vizualizaciji dišnog puta, iako on definitivno predstavlja novu budućnost. U svakom slučaju, koji kod bio pristup vizualizaciji, nijedan bolesnik ne umire zbog propuštene vizualizacije ili neuspjele intubacije, već umire zbog neuspješne ventilacije koja ostaje bez sumnje zlatni standard bilo kojeg cilja za sigurnost bolesnika i tehnike zbrinjavanja dišnog puta

Frontiers in interventional cardiology

n more than 20 years since the first percutaneous coronary revascularization procedures, the field of interventional cardiology has proliferated beyond all expectations. Now more than 1 million procedures are performed worldwide each year. Stenting has revolutionized the field, which previously relied on balloon dilatation in the majority of patients. With 50% of patients now undergoing stent implantation, the groundwork is laid for further important advances. In this article, we discuss the 4 most important new advances in the field of interventional cardiology: platelet inhibition, prevention of restenosis, stent evolution, and angiogenesis

Bringing high-grade arteriovenous malformations under control: clinical outcomes following multimodality treatment in children.

OBJECTIVE:Brain arteriovenous malformations (AVMs) consist of dysplastic blood vessels with direct arteriovenous shunts that can hemorrhage spontaneously. In children, a higher lifetime hemorrhage risk must be balanced with treatment-related morbidity. The authors describe a collaborative, multimodal strategy resulting in effective and safe treatment of pediatric AVMs. METHODS:A retrospective analysis of a prospectively maintained database was performed in children with treated and nontreated pediatric AVMs at the University of California, San Francisco, from 1998 to 2017. Inclusion criteria were age ≤ 18 years at time of diagnosis and an AVM confirmed by a catheter angiogram. RESULTS:The authors evaluated 189 pediatric patients with AVMs over the study period, including 119 ruptured (63%) and 70 unruptured (37%) AVMs. The mean age at diagnosis was 11.6 ± 4.3 years. With respect to Spetzler-Martin (SM) grade, there were 38 (20.1%) grade I, 40 (21.2%) grade II, 62 (32.8%) grade III, 40 (21.2%) grade IV, and 9 (4.8%) grade V lesions. Six patients were managed conservatively, and 183 patients underwent treatment, including 120 resections, 82 stereotactic radiosurgery (SRS), and 37 endovascular embolizations. Forty-four of 49 (89.8%) high-grade AVMs (SM grade IV or V) were treated. Multiple treatment modalities were used in 29.5% of low-grade and 27.3% of high-grade AVMs. Complete angiographic obliteration was obtained in 73.4% of low-grade lesions (SM grade I-III) and in 45.2% of high-grade lesions. A periprocedural stroke occurred in a single patient (0.5%), and there was 1 treatment-related death. The mean clinical follow-up for the cohort was 4.1 ± 4.6 years, and 96.6% and 84.3% of patients neurologically improved or remained unchanged in the ruptured and unruptured AVM groups following treatment, respectively. There were 16 bleeding events following initiation of AVM treatment (annual rate: 0.02 events per person-year). CONCLUSIONS:Coordinated multidisciplinary evaluation and individualized planning can result in safe and effective treatment of children with AVMs. In particular, it is possible to treat the majority of high-grade AVMs with an acceptable safety profile. Judicious use of multimodality therapy should be limited to appropriately selected patients after thorough team-based discussions to avoid additive morbidity. Future multicenter studies are required to better design predictive models to aid with patient selection for multimodal pediatric care, especially with high-grade AVMs